Link Biologics
PrivateLast Round
Strategic
Sep 12, 2023
Company Overview
Link Biologics is a biopharmaceutical company that develops protein biologics based on TSG-6 for people living with inflammatory and degenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Biologics Comparables
Compare Link Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OKYO Pharma | 75% | |
| Selagine, Inc. | 73% | |
| Stuart Therapeutics, Inc. | 71% | |
Link Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 12, 2023 | ||||
| Accelerator | Jun 1, 2022 |
Link Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Destruction Lab | Accelerator |
| Théa Open Innovation | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 169% MoM, from 75 to 202.
- Dec 7, 2025
Monthly visitors grew 137% MoM, from 41 to 97.
Link Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Link Biologics's valuation, stock price, and market status.